Drugs & Targets IBM Watson Health and Quest Diagnostics launched IBM Watson Genomics from Quest Diagnostics October 21, 2016Vol.42 No.39
Drugs & Targets CDC recommended 11-to-12-year-olds receive two doses of HPV vaccine October 21, 2016Vol.42 No.39
Drugs & Targets Onivyde in combination with 5-fluorouracil and leucovorin received marketing authorization from The European Commission October 21, 2016Vol.42 No.39
Drugs & Targets Venclyxto granted a positive opinion from the European Committee for Medicinal Products for Human Use October 21, 2016Vol.42 No.39
Drugs & Targets Genentech receives second Breakthrough Therapy Designation from FDA for Alecensa October 20, 2016Vol.39 No.09
Drugs & Targets Abbvie said Health Canada issued a Notice of Compliance with Conditions for Venclexta October 14, 2016Vol.42 No.38
Drugs & Targets Foundation Medicine, Inc. announces new clinical markers added to FoundationOne and FoundationOne Heme products October 14, 2016Vol.42 No.38
Drugs & Targets Genentech receives second Breakthrough Therapy Designation from FDA for Alecensa October 14, 2016Vol.42 No.38
Drugs & Targets The US Oncology Network selects Myriad Genetics as its preferred provider laboratory for hereditary cancer testing October 14, 2016Vol.42 No.38
